Effect of immunization with an inactivated gp120-depleted HIV-1 immunogen on β-chemokine and cytokine production in subjects with HIV-1 infection

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 14, Issue 4, 1997, Pages 343-350

  Moss, Ronald B ^a   Trauger, Richard J ^a   Giermakowska, Wieslawa K ^a   Turner, John L ^b   Wallace, Mark R ^c   Jensen, Fred C ^a   Richieri, Steven P ^a   Ferre, Francois ^a   Daigle, Anne E ^a   Duffy, Christopher ^a   Theofan, Georgia ^a   Carlo, Dennis J ^a  

^a Orchestra Therapeutics Inc   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c Space and Naval Warfare Systems Center Pacific   (United States)

Author keywords

CD8 T cells; Cellular immunity; Cytokines; HIV 1; Interferon ; RANTES

Indexed keywords

GAMMA INTERFERON; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; RANTES;

ACTIVE IMMUNIZATION; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG DESIGN; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENICITY; INTERFERON PRODUCTION; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; PRIORITY JOURNAL;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 12644259477     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199704010-00006     Document Type: Article

References (23)

1. Klein MR, van Baalen CA, Holwcrda AM, et al. Kinetics of gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J Exp Med 1995;181:1365-72.
2. Rinaldo C, Huang X, Fan Z, et al. High levels of anti-human immunodeticiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infectcd long-term nonprogressors. J Virol 1995;69:5838-42.
3. Clerici M, Shearer G. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today 1994;15:575-81.
4. H0 cells. Science 1994;265:244-8.
5. + T-cell clones in human immunodeficiency virus infection. Blood 1994; 84:4262-8.
6. + T cells. Science 1995;270:1811-5.
7. Alkhatib G, Combadiere C, Broder C, et al. CC CKR5: a RANTES. MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272:1955-8.
8. Oravecz T, Pall M, Norcross MA, β-Chemokine inhibitor of monocytotropic HIV-1 infection. J Immunol 1996;57: 1329-32.
9. Deng H, Liu R, Ellmeier W, et al. Identification of a major coreceptor for primary isolates of HIV-1. Nature 1996;381:661-6.
10. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996;381:667-73.
11. Salk J, Prospects for the control of AIDS by immunizing seropositive individuals. Nature 1987;327:473-6.
12. Trauger RJ, Ferre F, Daigle AE, et al. Effect of immunization with inactivated gp120-depleted human immunodeficiency virus type 1 (HIV-1) immunogen on HIV-1 immunity, viral DNA. and percentage of CD4 cells. J Infect Dis 1994; 169:1256-64.
13. Turner JL, Trauger RJ, Daigle AE, Carlo DJ. HIV-1 immunogen induction of HIV-1-specific delayed-type hypersensitivity: results of a double-blind, adjuvant-controlled, dose-ranging trial. AIDS 1994;8:1429-35.
14. Levine AM, Groshen S, Allen J, et al. Initial studies on active immunization of HIV-1 infected subjects using a gp120-depleted HIV-1 immunogen: long-term follow-up. J Acquir Immune Delk Syndr 1996;11:351-64.
15. Trauger RJ, Giermakowska WK, Ferre F, et al. Cell-mediated immunity to HIV-1 in Walter Reed stages 1-6 individuals: correlation with virus burden. Immunology 1993;78:611-5.
16. Revets H, Marissens D, De Wit S, Lacor P, Clumeck N, Lauwers S, Zissis G. Comparative Evaluation of NASBA HIV-1 RNA QT, AMPLICOR-HIV Monitor, and QUANTIPLEX HIV RNA assay: three methods for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 1996;34:1058-64.
17. Devergne O, Marfaing-Koka A, Schall TT, et al. Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells. J Exp Med 1994;179:1689-94.
18. + cell response against human immunodeficiency virus: implications for long-term survival. Proc Natl Acad Sci U S A 1995;92:11135-9.
19. Paxton W, Martin SR, Tse D, et al. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nat Med 1996;2:412-7.
20. + T cells of HIV-infecied individuals is regulated by a balance between the viral suppressive effects of endogenous chemokines and the viral inductive effect of other endogenous cytokines. Proc Natl Acad Sci U S A 1996;93:14076-81.
21. Embretson J, Zupancic M, Ribas JL, et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993; 362:359-62.
22. + cell counts, and HIV-1 production by cells. Science 1996;271:670-1.
23. Moss RB, Ferre F, Levine A, et al. Viral load CD4 percentage and delayed-type hypersensitivity in subjects receiving the HIV-1 immunogen and antiviral drug therapy. J Clin Immunol 1996;16:266-71.